График акции UroGen Pharma Ltd.
Расширенный график
Простой график
О компании
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. ПодробнееВыручка | 1.8E-5 |
---|---|
EBITDA | -0.1082 |
P/S | 36358.66 |
P/BV | 3.63 |
EV/EBITDA | -5.62 |
Цена ао | 15.17 |
ISIN | IL0011407140 |
Число акций ао | 0.02883 млрд |
Сайт | https://www.urogen.com |
Валюта | usd |
IPO date | 2017-05-04 |
Sector | Health Care |
Industry | Biotechnology |
Валюта отчета | usd |
Изменение цены за день: | 0% (12.26) |
---|---|
Изменение цены за неделю: | +3.11% (11.89) |
Изменение цены за месяц: | -7.12% (13.2) |
Изменение цены за 3 месяца: | -26.32% (16.64) |
Изменение цены за полгода: | -10.71% (13.73) |
Изменение цены за год: | +5.06% (11.67) |
Изменение цены за 3 года: | -27.63% (16.94) |
Изменение цены за 5 лет: | -64.41% (34.45) |
Изменение цены с начала года: | -18.54% (15.05) |
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
Институционалы | Объем | Доля, % |
---|---|---|
Great Point Partners LLC | 2620545 | 8.49 |
Menora Mivtachim Holdings Ltd. | 2303031 | 7.46 |
RA Capital Management, L.P. | 1483697 | 4.81 |
Blackrock Inc. | 1197647 | 3.88 |
Credit Suisse Ag/ | 1060000 | 3.43 |
Harel Insurance Investments & Financial Services Ltd. | 870194 | 2.82 |
RTW Investments LP | 857464 | 2.78 |
Migdal Insurance & Financial Holdings Ltd. | 648302 | 2.1 |
SILVERARC CAPITAL MANAGEMENT, LLC | 508883 | 1.65 |
Wildcat Capital Management, LLC | 495606 | 1.61 |
ETF | Доля, % | Доходность за год, % | Дивиденды, % |
---|---|---|---|
ARK Israel Innovative Technology ETF | 1.67779 | 24.386356391457 | 1.21688 |
ProShares Ultra Nasdaq Biotechnology | 0.03147 | 39.619651347068 | 0.85651 |
Fidelity MSCI Health Care Index ETF | 0.00575 | 18.888144675151 | 1.46057 |
Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.02471 | 24.285974167728 | 1.41955 |
SPDR S&P International Small Cap ETF | 0.03065 | 15.850144092219 | 3.10348 |
ProShares Hedge Replication ETF | 0.00273 | 5.5087969920031 | 1.47892 |
Invesco Nasdaq Biotechnology ETF | 0.04838 | 19.919314170449 | 0.8565 |
Amplify BlueStar Israel Technology ETF | 0.57399 | 23.045157411512 | 0.47569 |
iShares Micro-Cap ETF | 0.12986 | 35.054312164247 | 1.54048 |
iShares Russell 2000 Growth ETF | 0.02916 | 34.028337203241 | 0.6026 |
iShares Russell 3000 ETF | 0.00087 | 36.935557303092 | 1.43482 |
SPDR Portfolio Developed World ex-US ETF | 0.00776 | 20.109963345551 | 3.28401 |
ProShares UltraPro Russell2000 | 0.01005 | 81.385281385281 | 1.47873 |
Vanguard Russell 3000 ETF | 0 | 35.867021276596 | 1.43817 |
Vanguard Russell 2000 Growth ETF | 0.03 | 34.809548656405 | 0.60264 |
Vanguard Russell 2000 ETF | 0.02 | 32.304263853811 | 1.48801 |
Principal Healthcare Innovators ETF | 0.05533 | 619.46509255211 | 0.8416 |
Future Tech ETF | 0.05533 | 402.81995661605 | 0.8416 |
Руководитель | Должность | Оплата | Год рождения |
---|---|---|---|
Ms. Elizabeth A. Barrett | President, CEO & Director | 1.12M | 1962 (62 года) |
Mr. Dong Kim | Chief Financial Officer | 546.68k | 1977 (47 лет) |
Mr. Jason Drew Smith | General Counsel, Chief Compliance Officer & Corporate Secretary | 717.58k | 1972 (52 года) |
Vincent I. Perrone | Senior Director of Investor Relations | N/A | |
Mr. Bryon Wornson | Executive Vice President of Talent, Advocacy & Communications | N/A | |
Dr. Mark P. Schoenberg M.D. | Chief Medical Officer | 579.5k | 1958 (66 лет) |
Mr. James Ottinger R.ph. | Executive Vice President of Regulatory Affairs & Quality | N/A | |
Dr. Marina Konorty Ph.D. | Executive Vice President of Research & Development and Technical Operations | ||
Dr. Polly A. Murphy D.V.M., M.B.A., Ph.D. | Chief Business Officer | 1965 (59 лет) | |
Mr. Michael J. Louie M.D., M.P.H., M.Sc. | Senior Vice President of Medical Affairs & Clinical Development |
Адрес: United States, Princeton. NJ, 400 Alexander Park - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.urogen.com
Сайт: https://www.urogen.com